"Arthritis, Rheumatoid" - Books

Result Filters

Results: 1 to 20 of 939 books (7215 items)

<< First< Prev

Page of 47

Next >Last >>

Select item 44036681.

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2021 Jan-.

Top results in this book Table of Contents

Select item 26591822.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].

York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Top results in this book Table of Contents

Select item 45904203.

Rheumatoid arthritis in adults: diagnosis and management.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (UK); 2018 Jul. (NICE Guideline, No. 100.)

Top results in this book Table of Contents

Select item 15027924.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet].

Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.

Top results in this book Table of Contents

Select item 44650645.

Autoimmunity: From Bench to Bedside [Internet].

Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al., editors.

Bogota (Colombia): El Rosario University Press; 2013 Jul 18.

Top results in this book Table of Contents

Select item 46313046.

Drugs for the Management of Rheumatoid Arthritis: Clinical Evaluation [Internet].

Wells GA, Smith C, Hossain A, et al.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Mar. (CADTH Health Technology Assessment, No. 146.)

Top results in this book Table of Contents

Select item 48538167.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.

Top results in this book Table of Contents

Select item 26253288.

InformedHealth.org [Internet].

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-.

Top results in this book Table of Contents

Select item 34012949.

Endotext [Internet].

Feingold KR, Anawalt B, Boyce A, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

Top results in this book Table of Contents

Select item 466909410.

Clinical Review Report: sarilumab (Kevzara) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 May.

Top results in this book Table of Contents

Select item 422113411.

Tocilizumab (Actemra): Adult Patients with Moderately to Severely Active Rheumatoid Arthritis [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Aug.

Top results in this book Table of Contents

Select item 460302812.

Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update [Internet].

Donahue KE, Gartlehner G, Schulman ER, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul. (Comparative Effectiveness Review, No. 211.)

Top results in this book Table of Contents

Select item 421769213.

Golimumab (Simponi) IV: In Combination with Methotrexate (MTX) for the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Jul.

Top results in this book Table of Contents

Select item 141528014.

Madame Curie Bioscience Database [Internet].

Austin (TX): Landes Bioscience; 2000-2013.

Top results in this book Table of Contents

Select item 500411215.

Clinical Review Report: Upadacitinib (Rinvoq): (AbbVie): Indication: For the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Mar.

Top results in this book Table of Contents

Select item 232206616.

Changing Health Care Systems and Rheumatic Disease.

Institute of Medicine (US) Committee on Changing Health Care Systems and Rheumatic Disease; Manning FJ, Barondess JA, editors.

Washington (DC): National Academies Press (US); 1996.

Top results in this book Table of Contents

Select item 487733617.

Clinical Review Report: Baricitinib (Olumiant): (Eli Lilly Canada Inc.): Indication: For use in combination with methotrexate (MTX) for the treatment of adult patients with moderate to severe rheumatoid arthritis who have responded inadequately to one or more disease-modifying antirheumatic drugs (DMARDs). Baricitinib may also be used as monotherapy in cases of intolerance to MTX [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Sep.

Top results in this book Table of Contents

Select item 425156018.

Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.

Stevenson M, Archer R, Tosh J, et al.

Southampton (UK): NIHR Journals Library; 2016 Apr. (Health Technology Assessment, No. 20.35.)

Top results in this book Table of Contents

Select item 296774419.

Adalimumab, Etanercept, Infliximab, Rituximab and Abatacept for the Treatment of Rheumatoid Arthritis After the Failure of a Tumour Necrosis Factor Inhibitor: A Systematic Review and Economic Evaluation.

Malottki K, Barton P, Tsourapas A, et al.

Southampton (UK): NIHR Journals Library; 2011 Mar. (Health Technology Assessment, No. 15.14.)

Top results in this book Table of Contents

Select item 487755620.

Pharmacoeconomic Review Report: Baricitinib (Olumiant): (Eli Lilly Canada Inc.): Indication: For use in combination with methotrexate (MTX) for the treatment of adult patients with moderate to severe rheumatoid arthritis who have responded inadequately to one or more disease-modifying antirheumatic drugs (DMARDs). Baricitinib may also be used as monotherapy in cases of intolerance to MTX [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Sep.

Top results in this book Table of Contents

<< First< Prev

Page of 47

Next >Last >>

Supplemental Content

Images search in Bookshelf

Summary keynotes on Rheumatoid Arthritis. Contributed by StatPearls

Rheumatoid Arthritis.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-.
Figure 1Analytic framework for drug therapy for early rheumatoid arthritis

csDMARD = conventional synthetic disease-modifying antirheumatic drug; KQ = Key Question; RA = rheumatoid arthritis; TNF = tumor necrosis factor; tsDMARD = targeted synthetic disease-modifying antirheumatic drug.

Introduction.

Donahue KE, Gartlehner G, Schulman ER, et al. Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul.
Figure 2Summary of literature search flow and yield for early rheumatoid arthritis

IPA = International Pharmaceutical Abstracts; NWMA = network meta-analysis; NY = New York; RA = rheumatoid arthritis; SEADs = supplemental evidence and data; WHO ICTRP = World Health Organization International Clinical Trials Registry Platform; yr = year.

Results.

Donahue KE, Gartlehner G, Schulman ER, et al. Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul.
FIGURE 5

Conceptual model of RA fatigue. Reproduced from Hewlett S, Chalder T, Choy E, Cramp F, Davis B, Dures E, et al., Fatigue in rheumatoid arthritis: time for a conceptual model, Rheumatology (Oxford), 2011, Volume 50, Issue 6, pp. 1004–6, by permission of Oxford University Press.19

Conceptual model of rheumatoid arthritis fatigue.

Hewlett S, Almeida C, Ambler N, et al. Group cognitive–behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations. Southampton (UK): NIHR Journals Library; 2019 Oct.